Holdings
Soleus Capital Management, L.P.
As of Sep 30, 2026, Soleus Capital Management, L.P. reported 88 positions worth US$2.58B. Largest: Krystal Biotech, Inc., Insulet Corporation and TG Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Krystal Biotech, Inc. | 1.14M | US$379M | +200K | Sep 30, 2026 |
| Insulet Corporation | 1.73M | US$225M | +678K | Sep 30, 2026 |
| TG Therapeutics, Inc. | 2.56M | US$143M | −372K | Sep 30, 2026 |
| United Therapeutics Corporation | 259K | US$140M | +33,413 | Sep 30, 2026 |
| Celcuity Inc. | 1.68M | US$134M | −21,558 | Sep 30, 2026 |
| Rigel Pharmaceuticals, Inc. | 1.84M | US$88.8M | no change | Sep 30, 2026 |
| Inspire Medical Systems, Inc. | 1.21M | US$83.7M | −725K | Sep 30, 2026 |
| Erasca, Inc. | 5.11M | US$74.9M | +2.41M | Sep 30, 2026 |
| Beta Bionics, Inc. | 3.74M | US$71.1M | −650K | Sep 30, 2026 |
| ANI Pharmaceuticals, Inc. | 976K | US$70.9M | +108K | Sep 30, 2026 |